MDM2 Protein Degraders
dc.contributor.author | Wang, shaomeng | |
dc.contributor.author | Li, Yangbing | |
dc.contributor.author | YANG, Jiuling | |
dc.contributor.author | Aguilar, Angelo | |
dc.contributor.author | Zhou, Bing | |
dc.contributor.author | HU, Jiantao | |
dc.contributor.author | Xu, Fuming | |
dc.contributor.author | Rej, Rohan | |
dc.contributor.author | Han, Xin | |
dc.coverage.spatial | US | |
dc.date.accessioned | 2022-09-17T01:56:46Z | |
dc.date.available | 2022-09-17T01:56:46Z | |
dc.date.submitted | 2016-04-01 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174698 | |
dc.description.abstract | Disclose non-peptide, small-molecule compounds that bind to human MDM2 protein and induce degradation of MDM2. Such compounds have the therapeutic potential for the treatment of human cancer, including both leukemia, lymphoma, breast, prostate, colon, lung, panceatic and other types of human cancers in which MDM2 plays a role. In addition to cancer treatment, small-molecule MDM2 degraders may also have an application for the treatment of other conditions, such as macular degeneration. | |
dc.title | MDM2 Protein Degraders | |
dc.type | Patent | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174698/2/79206568_1537160410.pdf | |
dc.identifier.doi | https://dx.doi.org/10.7302/6429 | |
dc.date.updated | 2022-09-17T01:56:42Z | |
dc.identifier.orcid | 0000-0003-0904-9137 | |
dc.identifier.name-orcid | Wang, shaomeng | |
dc.identifier.name-orcid | Li, Yangbing | |
dc.identifier.name-orcid | YANG, Jiuling | |
dc.identifier.name-orcid | Aguilar, Angelo | |
dc.identifier.name-orcid | Zhou, Bing | |
dc.identifier.name-orcid | HU, Jiantao | |
dc.identifier.name-orcid | Xu, Fuming | |
dc.identifier.name-orcid | Rej, Rohan; 0000-0003-0904-9137 | |
dc.identifier.name-orcid | Han, Xin | |
dc.working.doi | 10.7302/6429 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.